Helix Biopharma Corp.
3-305 Industrial Parkway
Aurora
Ontario
L4G 6X7
Canada
Tel: 905-841-2300-Ext-232
Fax: 905-841-2244
Website: http://www.helixbiopharma.com/
291 articles about Helix Biopharma Corp.
-
Helix Biopharma Appoints Evolution Life Science Partners As Advisors
6/3/2016
-
Helix Biopharma Subsidiary, Helix Polska Sp zo.o., Qualifies For CAD4.1 Million Grant From The Polish National Center For Research And Development
5/10/2016
-
Helix Biopharma Closes CAD4.7 Million Private Placement Financing
5/2/2016
-
Helix Biopharma Release: Trial Steering Committee Recommends Initiation Of Phase II L-DOS47 Study In Non-Small Cell Lung Cancer
4/25/2016
-
Helix Biopharma Announces Important Additions To Its Leadership Team
4/21/2016
-
Helix Biopharma Announces The Receipt Of Subscription Agreements Totalling CAD4.7 Million For Private Placement Financing
4/18/2016
-
Helix Biopharma CEO Steps Down for Personal Reasons
3/30/2016
-
Helix Biopharma Announces Second Quarter Fiscal 2016 Results
3/17/2016
-
Helix Biopharma Reports On Advancement Of Its L-DOS47 Phase I/II Study In Poland
3/9/2016
-
Helix Biopharma Reports On Advancement Of Its Lung Cancer Drug Candidate L-DOS47
3/4/2016
-
Helix Biopharma Announces Appointment Of New Directors To The Board Of Directors
2/1/2016
-
Helix Biopharma Initiates Enrollment In The Second Dosing Cohort Of U.S. Combination Treatment Study Of Its Lung Cancer Drug Candidate L-DOS47
1/22/2016
-
Helix Biopharma Announces Appointment Of Permanent New CEO And Changes At Board Level
1/12/2016
-
Helix Biopharma Transfers Technology To Poland
1/8/2016
-
Helix Biopharma Initiates Enrollment For Fifteenth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47
12/23/2015
-
Helix Biopharma Announces The Results Of Its Annual General Meeting
12/17/2015
-
Helix Biopharma Announces First Quarter 2016 Results
12/14/2015
-
Helix Biopharma Initiates Enrollment For Fourteenth Cohort In Polish Phase I/II Clinical Study Of Its L-DOS47 Lung Cancer Drug
11/4/2015
-
Helix Biopharma Announces Fiscal 2015 Results
10/30/2015
-
Helix Biopharma Announces Appointment Of A New Director And Leadership Transition Plans
9/30/2015